Meritage Portfolio Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-53,950
Closed -$7.87M 225
2017
Q3
$7.87M Buy
53,950
+915
+2% +$125K 0.77% 30
2017
Q2
$6.89M Buy
53,035
+19,260
+57% +$2.36M 0.71% 36
2017
Q1
$4.2M Buy
+33,775
New +$4.04M 0.44% 108
2016
Q1
Sell
-35,917
Closed -$4.3M 208
2015
Q4
$4.3M Buy
35,917
+74
+0.2% +$8.56K 0.48% 108
2015
Q3
$3.88M Buy
35,843
+1,185
+3% +$147K 0.45% 121
2015
Q2
$4.01M Buy
34,658
+170
+0.5% +$19.4K 0.42% 144
2015
Q1
$3.98M Buy
34,488
+690
+2% +$82.5K 0.4% 147
2014
Q4
$3.78M Buy
+33,798
New +$3.56M 0.4% 143

Other funds holding CELG

Meritage Portfolio Management's CELG Position: Q4 2017 in Review

Meritage Portfolio Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 53,950 shares — an estimated $7.87M sold.

Meritage Portfolio Management first reported a position in CELG in Q4 2014 and held it in 8 quarters. The position peaked at $7.87M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Meritage Portfolio Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Meritage Portfolio Management sold 53,950 Celgene Corp shares in Q4 2017, an estimated $7.87M.
  • Meritage Portfolio Management first reported a position in Celgene Corp in Q4 2014 and held it in 8 quarters.
  • Meritage Portfolio Management's Celgene Corp position peaked at $7.87M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Meritage Portfolio Management's 13F filing for Q4 2017, filed 29 Jan 2018.